XJPX
7741
Market cap57bUSD
Jun 18, Last price
28,515.00JPY
1D
3.24%
1Q
2.57%
Jan 2017
480.64%
Name
Hoya Corp
Chart & Performance
P/E
47.20
P/S
11.01
EPS
604.17
Div Yield, %
0.87%
Shrs. gr., 5y
-1.65%
Rev. gr., 5y
8.26%
Revenues
866.03b
+13.56%
Net income
202.10b
+11.43%
CFO
235.11b
+5.53%
Dividend
Sep 29, 2025125 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in Tokyo, Japan, in 1941, HOYA Corporation operates as a global med-tech enterprise and a leading provider of advanced technological and medical solutions. Its extensive "life care" division offers a diverse portfolio, ranging from ophthalmic products like eyeglasses and contact lenses to sophisticated medical instruments such as endoscopes, intraocular lenses, laparoscopic surgical tools, and automated endoscope cleaning systems. This segment also supplies various medical-related items, including prosthetic ceramic fillers and metallic implants. Furthermore, HOYA manages Eyecity, a specialized retail chain for contact lenses. Beyond healthcare, the company is a significant contributor to the information technology sector, manufacturing critical components like mask blanks and photomasks for semiconductor and liquid crystal display production, as well as glass disks for hard disk drives. Their imaging product range encompasses optical glasses, lenses, colored glass filters, and laser/UV light resources. Additionally, HOYA develops software solutions, notably ReadSpeaker for speech synthesis, and provides cloud-based services such as Kinnosuke for time and attendance management, and Yonosuke for electronic payslip distribution.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||